Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Current Assets (2024 - 2025)

Historic Current Assets for Kairos Pharma (KAPA) over the last 2 years, with Q2 2025 value amounting to $4.8 million.

  • Kairos Pharma's Current Assets changed N/A to $4.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $4.8 million, marking a year-over-year change of. This contributed to the annual value of $4.2 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q2 2025, Kairos Pharma's Current Assets is $4.8 million.
  • In the past 5 years, Kairos Pharma's Current Assets registered a high of $6.0 million during Q1 2025, and its lowest value of $4.2 million during Q4 2024.